Point72 Middle East FZE’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-27,236
Closed -$327K 232
2023
Q4
$327K Sell
27,236
-17,714
-39% -$145K 0.01% 939
2023
Q3
$315K Buy
+44,950
New +$415K 0.01% 919
2023
Q2
Sell
-22,697
Closed -$207K 1591
2023
Q1
$207K Buy
+22,697
New +$290K 0.01% 939

Other funds holding CDNA

Point72 Middle East FZE's CDNA Position: Q1 2024 in Review

Point72 Middle East FZE sold out of CareDx (CDNA) in Q1 2024, closing a stake of 27,236 shares — an estimated $327K sold.

Point72 Middle East FZE first reported a position in CDNA in Q1 2023 and held it in 3 quarters. The position peaked at $327K in Q4 2023. 147 funds tracked by Wall St. Rank hold CDNA as of Q1 2024.

  • Point72 Middle East FZE reported no remaining CareDx position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 27,236 CareDx shares in Q1 2024, an estimated $327K.
  • Point72 Middle East FZE first reported a position in CareDx in Q1 2023 and held it in 3 quarters.
  • Point72 Middle East FZE's CareDx position peaked at $327K in Q4 2023.
  • 147 funds tracked by Wall St. Rank held CareDx as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.